CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.
about
Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancerIndividualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcarePreoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
P2860
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@en
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@nl
type
label
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@en
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@nl
prefLabel
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@en
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@nl
P2093
P2860
P1433
P1476
CEA but not CA19-9 is an indep ...... section of cholangiocarcinoma.
@en
P2093
Alexander Koch
Anne T Schneider
Christian Trautwein
Christoph Roderburg
Cornelis H Dejong
Frank Tacke
Georg Lurje
Katja L Kauertz
Marcel Binnebösel
Mihael Vucur
P2860
P2888
P356
10.1038/S41598-017-17175-7
P407
P577
2017-12-05T00:00:00Z
P6179
1093099566